A new report suggests President Donald Trump may push for an unproven vaccine for coronavirus from the United Kingdom to be made available in the United States just one month before voters are set to decide if he deserves another term in office.
The Financial Times reported on Monday that Democrats in Congress were briefed in July about the administration’s considerations for the vaccine, a person familiar with the meeting told the publication. According to the article, Speaker of the House Nancy Pelosi (D-California) tried to warn White House officials during that meeting that there couldn’t be any “cutting corners” with the vaccine if it could potentially be harmful to those who opt to get it.
Trump administration officials disputed the reporting, saying the fast-tracking of a vaccine for emergency use authorization isn’t being considered at this time.
A vaccine for COVID-19, touted by Trump as the answer to stopping the spread of coronavirus in the U.S., could indeed be an “October surprise” that would be beneficial to his reelection chances.
The president has struggled on the issue of how the American public perceives his handling of the pandemic, which has consistently been negative. Numbers from this week show that just 31 percent of Americans approve of how Trump has managed the crisis, while 68 percent disapprove, according to a recent Associated Press/NORC Center for Public Affairs Research poll released on Monday.
The British vaccine in question has seen some success in testing with a small sample of 1,000 patients. There have also been some documented side effects, however, and there’s no concluding evidence yet that the vaccine would be effective in preventing the spread of COVID-19.
The reporting from The Financial Times, if accurate, may showcase how frantic Trump is to find a cure or vaccine for coronavirus ahead of Election Day in November. The president has frequently promoted a number of treatments for the disease, touting them as being tremendous developments in the fight against its spread. However, many of the remedies he has promoted over the past few months have been questionable at best, and outright dangerous in some instances.
Earlier this week, Trump touted using convalescent plasma, where antibodies from the blood of a patient who has recovered from COVID-19 is transfused into a patient currently afflicted with it, as a “breakthrough” for treating the virus, after the Food and Drug Administration (FDA) permitted emergency use authorization for the treatment.
“This is a powerful therapy that transfuses very, very strong antibodies from the blood of recovered patients to help patients battling an infection,” Trump said in a statement at the White House on Sunday. “It’s had an incredible rate of success.”
Yet the high success rate Trump is suggesting is being questioned by health experts in the U.S. and around the world. The World Health Organization (WHO), for example, has noted that not enough research has been conducted to make such conclusive remarks.
“We recommend that convalescent plasma is still an experimental therapy. It should be evaluated in well-designed, randomized, clinical trials,” WHO’s chief scientist Soumya Swaminathan said, adding that there’s “very low-quality evidence” to say it’s as effective as Trump makes it out to be.
Thomas File, president of the Infectious Diseases Society of America, also urged caution when pushing the treatment.
“While the data to date show some positive signals that convalescent plasma can be helpful in treating individuals with COVID-19, especially if given early in the trajectory of disease, we lack the randomized controlled trial data we need to better understand its utility in COVID-19 treatment,” he recently said.
In promoting the treatment, the White House cited a study from the Mayo Clinic that suggested 35 percent of patients who received the convalescent plasma were more likely to survive another 30 days of coronavirus versus those who didn’t. However, that study noted its own limitations, including the lack of a placebo group with which to compare the findings.
The FDA has permitted a treatment promoted by Trump before — the malaria drug hydroxychloroquine — for emergency use, only to later strip that authorization after it was determined through a number of studies that use of the drug to treat coronavirus was ineffective, and what’s worse, potentially dangerous. In spite of their removing the emergency use authorization for the drug, Trump continued to peddle it, including weeks later when he tweeted a video that stated hydroxychloroquine was a “cure” for the disease.
Truthout Is Preparing to Meet Trump’s Agenda With Resistance at Every Turn
Dear Truthout Community,
If you feel rage, despondency, confusion and deep fear today, you are not alone. We’re feeling it too. We are heartsick. Facing down Trump’s fascist agenda, we are desperately worried about the most vulnerable people among us, including our loved ones and everyone in the Truthout community, and our minds are racing a million miles a minute to try to map out all that needs to be done.
We must give ourselves space to grieve and feel our fear, feel our rage, and keep in the forefront of our mind the stark truth that millions of real human lives are on the line. And simultaneously, we’ve got to get to work, take stock of our resources, and prepare to throw ourselves full force into the movement.
Journalism is a linchpin of that movement. Even as we are reeling, we’re summoning up all the energy we can to face down what’s coming, because we know that one of the sharpest weapons against fascism is publishing the truth.
There are many terrifying planks to the Trump agenda, and we plan to devote ourselves to reporting thoroughly on each one and, crucially, covering the movements resisting them. We also recognize that Trump is a dire threat to journalism itself, and that we must take this seriously from the outset.
After the election, the four of us sat down to have some hard but necessary conversations about Truthout under a Trump presidency. How would we defend our publication from an avalanche of far right lawsuits that seek to bankrupt us? How would we keep our reporters safe if they need to cover outbreaks of political violence, or if they are targeted by authorities? How will we urgently produce the practical analysis, tools and movement coverage that you need right now — breaking through our normal routines to meet a terrifying moment in ways that best serve you?
It will be a tough, scary four years to produce social justice-driven journalism. We need to deliver news, strategy, liberatory ideas, tools and movement-sparking solutions with a force that we never have had to before. And at the same time, we desperately need to protect our ability to do so.
We know this is such a painful moment and donations may understandably be the last thing on your mind. But we must ask for your support, which is needed in a new and urgent way.
We promise we will kick into an even higher gear to give you truthful news that cuts against the disinformation and vitriol and hate and violence. We promise to publish analyses that will serve the needs of the movements we all rely on to survive the next four years, and even build for the future. We promise to be responsive, to recognize you as members of our community with a vital stake and voice in this work.
Please dig deep if you can, but a donation of any amount will be a truly meaningful and tangible action in this cataclysmic historical moment.
We’re with you. Let’s do all we can to move forward together.
With love, rage, and solidarity,
Maya, Negin, Saima, and Ziggy